Klinger Biotech Consulting ApS

CVR 45113809 · Private limited company (ApS) · Active · Low risk

Klinger Biotech Consulting ApS is a Private limited company (ApS), founded on , based in Værløse. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 355k and a net result of DKK 315k. CEO: Markus Klinger.

Bankruptcy risk for Klinger Biotech Consulting ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Published annual reports1 · bankruptcy rate 18.7%2.1×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
45113809
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
Bakkehegnet 7A, 1.
3500 Værløse
Municipality
Ballerup
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityNo
Equity ratio77.2%
Current ratio440%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address3
Going-concern uncertaintyNo

Financials and key figures

Financial year2025
Gross profitDKK 1.5m
Net profitDKK 315k
EquityDKK 355k
Total assetsDKK 459k
CashDKK 312k
Short-term debtDKK 104k
Tax owedDKK 1,254
Avg. employees1

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Oct 2024 – 31 Dec 2025166

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMarkus KlingerCurrent
Owner (100%)Klinger Holding ApSCurrent
FounderKlinger Holding ApSCurrent

The CEOs' other companies

Markus Klinger – 1 other companies

Address history (0 moves)

Bakkehegnet 7A, 1., 3500 Værløse

Other companies at the same address

Similar companies in Ballerup

Questions and answers about Klinger Biotech Consulting ApS

Has Klinger Biotech Consulting ApS gone bankrupt?

No, Klinger Biotech Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Klinger Biotech Consulting ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of Klinger Biotech Consulting ApS?

Markus Klinger is the CEO of Klinger Biotech Consulting ApS.

When was Klinger Biotech Consulting ApS founded?

Klinger Biotech Consulting ApS was founded on 27 September 2024.

What is the equity of Klinger Biotech Consulting ApS?

Equity was DKK 355k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.